Opentrons develops the integrated lab platform that serves life science and healthcare customers via the Opentrons Robotics, Pandemic Response Lab, and Neochromosome subsidiaries. Opentrons Robotics is a business unit of Opentrons Labworks Inc and is the industry leader in flexible, user-friendly lab automation. Opentrons Robotics flagship product, the OT-2, can be found in thousands of labs in more than 40 countries
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/23/21 | $200,000,000 | Series C |
Lerer Hippeau Ventures Sands Capital SoftBank Vision Fund 2  SOSV Y Combinator | undisclosed |
